Skip to main content
SpringerLink
Log in

Interaction of newly synthesized antiprogesterone ZK98299 with progesterone receptor from human myometrium

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We have undertaken characterization of binding of the newly synthesized progesterone receptor (PR) antagonist ZK98299 in the cellular fractions of human myometrium. Specific [3H]progesterone and [3H]ZK98299 binding was observed in the cytosol and the nuclear fractions, and could be competitively replaced by either of the steroids in their radioinert form. Although PR occupied by both steroids exhibited nuclear uptake, the extent of nuclear binding was lower with [3H]ZK98299-receptor complexes. The binding of both ligands to PR was a function of the duration of incubation and the protein concentration: it was saturable at 3–6 nM steroids with a dissociation constant of approximately 2 nM. However, the number of ZK98299 binding sites (72 fmoles/mg protein) was lower compared to that of progesterone (322 fmoles/mg protein). The relative binding affinity (RBA) of ZK98299 for the nuclear PR was about 33% that of progesterone. The results of our study suggest that ZK98299 binds to PR in the cytosol and the nuclear fractions. The antiprogestin effects of ZK98299 reported in the literature are PR-mediated and may result from suboptimal nuclear binding/retention of antiprogestin-receptor complexes. Since this study did not involve isolation and study of individual PR isoforms, PR-A and PR-B, the present data should be viewed as representing an average of contributions by the two receptor forms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yamamoto KR: Steroid receptor regulated transcription of specific genes and gene networks. Ann Rev Genet 19: 209–252, 1985

    PubMed  Google Scholar 

  2. Baulieu EE: Contragestation and other clinical applications of RU486, an antiprogesterone at the receptors. Science 245: 1351–1357, 1989

    PubMed  Google Scholar 

  3. Gravanis A, Schaison G, George M, De Brux J, Satyaswaroop PG, Baulieu EE, Robel P: Endometrial and pituitary responses for the steroidal antiprogestin RU486 in post menopausal women. J Clin Endocrinol Metab 60: 156–163, 1985

    PubMed  Google Scholar 

  4. Pongubala JMR, Elger WAG, Puri CP: Relative binding affinity of ZK98.299 and ZK98.374 for progesterone receptors in the endometrium and myometrium of bonnet monkeys. J Recep Res 7: 903–920, 1987

    Google Scholar 

  5. Puri CP, Hinduja IN, D'souza A, Elger WAG, Pongubala JMR. Binding characteristics of progesterone and antiprogestin ZK98299 in human endometrial and myometrial cytosol. Biochim Biophys Acta 1011: 176–182, 1989

    PubMed  Google Scholar 

  6. Mizutani T, Bhakta A, Kloosterboer HJ, Moudgil VK: Novel antiprogestins Org 31806 and Org 31710: Interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes. J Steroid Biochem Molec Biol 42: 696–704, 1992

    Google Scholar 

  7. Puri CP, Van Look PFA: Newly developed competitive progesterone antagonists for fertility control. In: Antihormones in Health and Disease (Agarwal MK, ed.) pp. 127–167, Karger Press, Basel, 1991

    Google Scholar 

  8. Ulmann A, Teutsch G, Philibert D: RU38486. Sci Amer 262: 42–48, 1990

    Google Scholar 

  9. Moudgil VK, Nath R, Bhakta A, Nakao M: ZK98299, a novel antiprogesterone that does not interact with chicken oviduct progesterone receptor. Biochim Biophys Acta 1094: 185–192, 1991

    PubMed  Google Scholar 

  10. Eliezer N, Hurd CB and Moudgil VK: Immunologically distinct binding molecules for progesterone and RU486 in the chick oviduct cytosol. Biochim Biophys Acta 929: 34–39, 1987

    PubMed  Google Scholar 

  11. Spilman CH, Gibson RE, Beuving DC, Campbell JA: Progestin and antiprogestin effects on progesterone receptor transformation. J Steroid Biochem 24: 383–389, 1986

    PubMed  Google Scholar 

  12. Moguilewsky M, Philibert D: RU38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J Steroid Biochem 20: 271–276, 1984

    PubMed  Google Scholar 

  13. Baulieu EE: RU486 (an antisteroid hormone) receptor structure and heat-shock protein molecular wight 90,000 (hsp 90). Human Reproduc 3: 541–547, 1988

    Google Scholar 

  14. Baulieu EE: Steroid hormone antagonists at the receptor level: A role for the heat-shock protein MW 90,000 (hsp 90). J Cell Biochem 35: 161–174, 1987

    PubMed  Google Scholar 

  15. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, and Horwitz KB: Antagonist occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7: 1256–1265, 1993

    PubMed  Google Scholar 

  16. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP: Human progesterone receptor A form is a cell and promoter specific repressor of human progesterone receptor B function. Mol Endocrinol 7: 1244–1255, 1993

    PubMed  Google Scholar 

  17. Puri CP, Elger WAG, Pongubala JMR: Induction of menstruation by antiprogestin ZK98299 in cycling bonnet monkeys. Contraception 35: 409–421, 1987

    PubMed  Google Scholar 

  18. Puri CP, Patil RK, D'souza A, Elger WAG, Pongubala JMR: Pharmacokinetics and pharmacodynamic effects of progesterone antagonist ZK98299 in female bonnet monkeys. In: Hormone Antagonists for Fertility Regulation (Puri CP, VanLook PFA, eds.) pp. 123–140, published by Indian Society for the Study of Reproduction and Fertility, Bombay, 1988

    Google Scholar 

  19. Nath R, Bhakta A, Moudgil VK: ZK98299 — A new antiprogesterone: Biochemical characterization of steroid binding parameters in the calf uterine cytosol. Arch Biochem Biophys 292: 303–310, 1992

    PubMed  Google Scholar 

  20. Schrader WT, Socher SH, Buller RE: Steroid hormone-receptor interactions with nuclear constituents. Methods Enzymol 36: 292–313, 1974

    Google Scholar 

  21. Buller RE, Toft DO, Schrader WT and O'Malley BW: Receptor activation and hormone dependent binding to purified nuclei. J Biol Chem 250: 801–808, 1975

    PubMed  Google Scholar 

  22. Burton K: A study of the conditions and mechanism of the diphenylamine reaction for the calorimetric estimation of DNA. Biochem J 62: 315–328, 1956

    PubMed  Google Scholar 

  23. Lowry OH, Roseburgh NJ, Farr NJ, Randall RJ: Protein measurement and folin reagent. J Biol Chem 193: 265–272, 1951

    PubMed  Google Scholar 

  24. Moudgil VK, Hurd C: Transformation of calf uterine progesterone receptor: Analysis of the process when receptor is bound to progesterone and RU38486. Biochemistry 26: 4993–5001, 1987

    PubMed  Google Scholar 

  25. Moudgil VK, Lombardo G, Hurd D, Eliezer N, Agarwal MK: Evidence for separate binding sites for progesterone and RU486 in the chicken oviduct. Biochim Biophys Acta 889: 192–199, 1986

    PubMed  Google Scholar 

  26. Moudgil VK, Anter MJ, Hurd C: Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands. J Biol Chem 264: 2204–2211, 1989

    Google Scholar 

  27. Bourgeois S, Pfahl M, Baulieu EE: DNA binding properties of glucocorticoid receptors bound to the steroidal antagonist RU486 EMBO 3: 751–755, 1984

    PubMed  Google Scholar 

  28. Guiochon-Mantel A, Loosfelt H, Ragot T, Bailly A, Atger M, Misrahi M, Pericaudet M, Milgrom E: Receptor bound antiprogestin form abortive complexes with hormone response elements. Nature 336: 695–698, 1988

    PubMed  Google Scholar 

  29. Delabre K, Guiochon-Mantel A, Milgrom E: In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA. Proc Natl Acad Sci USA 90: 4421–4425, 1993

    PubMed  Google Scholar 

  30. Horwitz KB: The molecular biology or RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocrine Rev 13 146–163, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Research in Reproduction (ICMR), Parel, 400012, Bombay, India

    Anil D'souza & Chander P. Puri

  2. K.E.M. Hospital and Seth G.S. Medical College, Parel, 400012, Bombay, India

    Indira N. Hinduja

  3. Department of Biological Sciences and Institute for Biochemistry and Biotechnology, Oakland University, 48309-4401, Rochester, MI, USA

    Sandhya Kodali & V. K. Moudgil

Authors
  1. Anil D'souza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Indira N. Hinduja
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandhya Kodali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. K. Moudgil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chander P. Puri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

D'souza, A., Hinduja, I.N., Kodali, S. et al. Interaction of newly synthesized antiprogesterone ZK98299 with progesterone receptor from human myometrium. Mol Cell Biochem 139, 83–90 (1994). https://doi.org/10.1007/BF00944206

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00944206

Key words

Search

Navigation